Literature DB >> 17554798

Fukutin-related protein localizes to the Golgi apparatus and mutations lead to mislocalization in muscle in vivo.

Elizabeth Keramaris-Vrantsis1, Pei J Lu, Timothy Doran, Allen Zillmer, Jignya Ashar, Christopher T Esapa, Matthew A Benson, Derek J Blake, Jeffrey Rosenfeld, Qi L Lu.   

Abstract

Mutations in the fukutin-related protein gene (FKRP) are associated with a spectrum of diseases from mild limb-girdle muscular dystrophy type 2I to severe congenital muscular dystrophy type 1C, muscle-eye-brain disease (MEB), and Walker-Warburg syndrome (WWS). The effect of mutations on the transportation of the mutant proteins may constitute the underlying mechanisms for the pathogenesis of these diseases. Here we examined the subcellular localization of mouse and human normal and mutant FKRP proteins in cells and in muscle in vivo. Both normal human and mouse FKRPs localize in part of the Golgi apparatus in muscle fibers. Mutations in the FKRP gene invariably altered the localization of the protein, leading to endoplasmic reticulum retention within cells and diminished Golgi localization in muscle fibers. Our results therefore suggest that an individual missense point mutation can confer at least two independent effects on the protein, causing (1) reduction or loss of the presumed glycosyltransferase activity directly and (2) mislocalization that could further alter the function of the protein. The complexity of the effect of individual missense point mutations may partly explain the wide variation of the FKRP-related myopathies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554798     DOI: 10.1002/mus.20833

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  14 in total

1.  Probing the oligomeric state and interaction surfaces of Fukutin-I in dilauroylphosphatidylcholine bilayers.

Authors:  P Marius; Yuk Ming Leung; T J Piggot; S Khalid; P T F Williamson
Journal:  Eur Biophys J       Date:  2011-11-11       Impact factor: 1.733

2.  Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration.

Authors:  Masaji Tachikawa; Motoi Kanagawa; Chih-Chieh Yu; Kazuhiro Kobayashi; Tatsushi Toda
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

3.  Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I.

Authors:  Chiara A Boito; Marina Fanin; Bruno F Gavassini; Giovanna Cenacchi; Corrado Angelini; Elena Pegoraro
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

4.  AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.

Authors:  Evelyne Gicquel; Natacha Maizonnier; Steven J Foltz; William J Martin; Nathalie Bourg; Fedor Svinartchouk; Karine Charton; Aaron M Beedle; Isabelle Richard
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

5.  Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].

Authors:  Chi-Hsien Wang; Yiumo Michael Chan; Ru-Hang Tang; Bin Xiao; Peijuan Lu; Elizabeth Keramaris-Vrantsis; Hui Zheng; Chunping Qiao; Jiangang Jiang; Juan Li; Hsin-I Ma; Qilong Lu; Xiao Xiao
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Expression and purification of the transmembrane domain of Fukutin-I for biophysical studies.

Authors:  P Marius; J N Wright; I S Findlow; P T F Williamson
Journal:  Protein Expr Purif       Date:  2010-02-01       Impact factor: 1.650

7.  Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis.

Authors:  Charles Kwok-chong Li; Paul Knopp; Halima Moncrieffe; Bhanu Singh; Sonia Shah; Kanneboyina Nagaraju; Hemlata Varsani; Bin Gao; Lucy R Wedderburn
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

8.  Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions.

Authors:  Lei Xu; Pei Juan Lu; Chi-Hsien Wang; Elizabeth Keramaris; Chunping Qiao; Bin Xiao; Derek J Blake; Xiao Xiao; Qi Long Lu
Journal:  Mol Ther       Date:  2013-07-02       Impact factor: 11.454

Review 9.  Muscular dystrophies due to defective glycosylation of dystroglycan.

Authors:  F Muntoni; M Brockington; C Godfrey; M Ackroyd; S Robb; A Manzur; M Kinali; E Mercuri; M Kaluarachchi; L Feng; C Jimenez-Mallebrera; E Clement; S Torelli; C A Sewry; S C Brown
Journal:  Acta Myol       Date:  2007-12

10.  Degree of Cajal-Retzius Cell Mislocalization Correlates with the Severity of Structural Brain Defects in Mouse Models of Dystroglycanopathy.

Authors:  Helen S Booler; Josie L Williams; Mark Hopkinson; Susan C Brown
Journal:  Brain Pathol       Date:  2015-10-12       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.